Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatiotemporal patterns and drivers of coupling coordination between digital technological innovation and economic resilience in the Yangtze river economic belt.

Scientific reports·2025
Same author

Design of a Thermoresponsive, Scalable, and Robust Recombinant Protein-Based Bioadhesive by Combining Elastin-like Polypeptide with Barnacle Cement Protein.

ACS biomaterials science & engineering·2025
Same author

SENP1 inhibits aerobic glycolysis in Aβ<sub>1-42</sub>-incubated astrocytes by promoting PUM2 deSUMOylation.

Cell biology and toxicology·2025
Same author

Unveil the mechanism for EHMT -- A novel triterpenoid inhibits proliferation and induces apoptosis in colon cancer through ROS-mediated JNK signaling pathway.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2024
Same author

Human Pluripotent Stem Cells Derived Endothelial Cells Repair Choroidal Ischemia.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2023
Same author

Enzyme-catalyzed high-performing reaction with in-situ amplified photocurrent on carbon-functionalized inorganic photoanode for immunosensing.

Biosensors & bioelectronics·2023
Same journal

Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4.

Apoptosis : an international journal on programmed cell death·2026
Same journal

Correction: Non-canonical cell death in neurodegeneration: emerging mechanisms and therapeutic Frontiers.

Apoptosis : an international journal on programmed cell death·2026
Same journal

Targeting the fibrosis-inflammation-oxidative stress axis: multifaceted mechanisms of salidroside in chronic organ fibrosis.

Apoptosis : an international journal on programmed cell death·2026
Same journal

Microglial tunneling nanotubes: an intercellular transfer facilitating mitochondrial dysfunction and neuroinflammation in experimental cerebral malaria.

Apoptosis : an international journal on programmed cell death·2026
Same journal

Copper dysregulation in cardiometabolic disease: copper deficiency versus cuproptosis.

Apoptosis : an international journal on programmed cell death·2026
Same journal

GPx6 downregulation drives ferroptosis in Kashin-Beck disease chondrocytes via the SLC7A11/GPx4 axis.

Apoptosis : an international journal on programmed cell death·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

16.3K

Evaluating DAPK as a therapeutic target.

Yide Huang1, Ling Chen, Libin Guo

  • 1Fujian Key Laboratory of Developmental and Neural Biology, College of Life Sciences, Fujian Normal University, Fuzhou, 350108, Fujian, People's Republic of China.

Apoptosis : an International Journal on Programmed Cell Death
|December 6, 2013
PubMed
Summary
This summary is machine-generated.

Death associated protein kinase 1 (DAPK) is a key kinase in cellular processes. Its dysregulation, often via gene methylation in cancer, presents therapeutic opportunities.

More Related Videos

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
10:41

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

Published on: June 7, 2019

7.9K

Related Experiment Videos

Last Updated: May 5, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

16.3K
Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
10:41

Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

Published on: June 7, 2019

7.9K

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Death associated protein kinase 1 (DAPK) is a serine/threonine kinase crucial for apoptosis, autophagy, and inflammation.
  • Misregulation of DAPK is implicated in diseases like cancer and neuronal death.
  • Gene methylation frequently silences DAPK in various cancers, leading to expression loss.

Purpose of the Study:

  • To review the pathological roles and functions of DAPK in disease.
  • To compare reagents that modulate DAPK expression or activity.
  • To discuss the potential and challenges of targeting DAPK therapeutically.

Main Methods:

  • Literature review of DAPK's role in disease.
  • Analysis of DAPK-targeting reagents.
  • Discussion of clinical application barriers and opportunities.

Main Results:

  • DAPK plays diverse roles in cellular processes and disease pathology.
  • Various reagents exist to manipulate DAPK expression and activity.
  • DAPK's complex functions present both therapeutic potential and challenges.

Conclusions:

  • DAPK is a significant factor in disease pathogenesis.
  • Targeting DAPK offers potential therapeutic avenues.
  • Further research is needed to overcome barriers for clinical application.